Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-33.67	22.31	33.63
Graham Fair Price	55.58	298437.94	191824.46
PEG	-84.36	0.08	-0.48
Price/Book	-10.02	0.88	0.98
Price/Cash Flow	-48.34	31.56	61.08
Prices/Earnings	-61.14	10.30	26.50
Price/Sales	-9.67	2.52	2.78
Price/FCF	-48.34	31.56	61.08
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.66	0.28	0.28
Operating Margin	53.77	0.07	0.05
ROA	128.65	0.02	< 0.005
ROE	< 0.005	0.02	131.54
ROIC	0.01	0.02	78.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.03	-25.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.29	0.57	96.87
EPS QOQ	-0.55	1.37	148.42
FCF QOQ	0.13	0.78	482.52
Revenue QOQ	< 0.005	0.02	1812.98
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	46.51	45.15	-2.92
Days Sales Outstanding (DSO)	33.47	33.23	-0.71
Inventory Turnover	1.94	1.99	3.01
Debt/Capitalization	0.02	0.02	2.33
Quick Ratio	1.55	1.55	-0.09
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	420263.91	429698.24	2.24
Cash	131474.08	145600.79	10.74
Capex	-7145.59	-5363.02	24.95
Free Cash Flow	6753.36	12026.27	78.08
Revenue	148157.37	150889.15	1.84
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.04	2.01	-1.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.19	-1.76	-47.36
Naive Interpretation	Member

06 - Financial Health · Bad

Rating